Bio-Rad(BIO) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Press Release Bio-Rad Reports Second-Quarter 2024 Financial Results HERCULES, Calif.—August 1, 2024 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quarter ended June 30, 2024. Second-quarter 2024 total net sales were $638.5 million, a decrease of 6.3 percent compared to $681.1 million reported for the second quarter of 2023. On a currency-neutral basis, quarterly sa ...